Literature DB >> 27027149

Traceless Production of Cyclic Peptide Libraries in E. coli.

Jaime E Townend1, Ali Tavassoli1.   

Abstract

Split intein circular ligation of peptides and proteins (SICLOPPS) is a genetically encoded method for the intracellular production of cyclic peptide libraries of around 100 million (10(8)) members that utilizes the Synechocystis sp PCC6803 (Ssp) DnaE split inteins. However, Ssp inteins are relatively slow splicing and intolerant of amino acid variation around the splice junction, potentially limiting the utility and composition of SICLOPPS libraries. In contrast, Nostoc punctiforme (Npu) DnaE split inteins not only splice significantly faster, they are also much more tolerant of amino acid variation around their splice junctions. Here, we report the use of engineered Npu inteins in SICLOPPS for the generation of cyclic peptide libraries and cyclic proteins. Despite their superior splicing characteristics, however, we observed a high level of toxicity from the Npu SICLOPPS constructs in E. coli. The observed toxicity was overcome though incorporation of an SsrA tag to target the spliced Npu inteins to the ClpXP complex for degradation. The resulting traceless Npu SICLOPPS inteins showed no toxicity to E. coli, demonstrating their potential for the production of cyclic peptide libraries for use in a variety of high-throughput screens.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27027149     DOI: 10.1021/acschembio.6b00095

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  10 in total

1.  Zika Virus Specific Diagnostic Epitope Discovery.

Authors:  Maite Sabalza; Cheryl A Barber; William R Abrams; Richard Montagna; Daniel Malamud
Journal:  J Vis Exp       Date:  2017-12-12       Impact factor: 1.355

2.  The Discovery of Peptide Macrocycle Rescuers of Pathogenic Protein Misfolding and Aggregation by Integrating SICLOPPS Technology and Ultrahigh-Throughput Screening in Bacteria.

Authors:  Dafni C Delivoria; Georgios Skretas
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Intein-Mediated Protein Engineering for Cell-Based Biosensors.

Authors:  Chungwon Kang; Keshab Lal Shrestha; San Kwon; Seungil Park; Jinsik Kim; Youngeun Kwon
Journal:  Biosensors (Basel)       Date:  2022-04-28

Review 4.  Approaches for peptide and protein cyclisation.

Authors:  Heather C Hayes; Louis Y P Luk; Yu-Hsuan Tsai
Journal:  Org Biomol Chem       Date:  2021-05-12       Impact factor: 3.876

5.  MacroEvoLution: A New Method for the Rapid Generation of Novel Scaffold-Diverse Macrocyclic Libraries.

Authors:  Jörn Saupe; Oliver Kunz; Lars Ole Haustedt; Sven Jakupovic; Christian Mang
Journal:  Chemistry       Date:  2017-08-07       Impact factor: 5.236

6.  Targeting Bacillus anthracis toxicity with a genetically selected inhibitor of the PA/CMG2 protein-protein interaction.

Authors:  Abigail L Male; Fedor Forafonov; Francesco Cuda; Gong Zhang; Siqi Zheng; Petra C F Oyston; Peng R Chen; E Diane Williamson; Ali Tavassoli
Journal:  Sci Rep       Date:  2017-06-08       Impact factor: 4.379

7.  Reprogramming the Transcriptional Response to Hypoxia with a Chromosomally Encoded Cyclic Peptide HIF-1 Inhibitor.

Authors:  Ishna N Mistry; Ali Tavassoli
Journal:  ACS Synth Biol       Date:  2016-11-23       Impact factor: 5.110

8.  Discovery, X-ray structure and CPP-conjugation enabled uptake of p53/MDM2 macrocyclic peptide inhibitors.

Authors:  Anselm F L Schneider; Joerg Kallen; Johannes Ottl; Patrick C Reid; Sebastien Ripoche; Stephan Ruetz; Therese-Marie Stachyra; Samuel Hintermann; Christoph E Dumelin; Christian P R Hackenberger; Andreas L Marzinzik
Journal:  RSC Chem Biol       Date:  2021-08-26

9.  A Luminescence-Based System for Identification of Genetically Encodable Inhibitors of Protein Aggregation.

Authors:  Travis J Nelson; Shuo Liang; Cliff I Stains
Journal:  ACS Omega       Date:  2020-05-29

10.  Intein-mediated backbone cyclization of entolimod confers enhanced radioprotective activity in mouse models.

Authors:  Bingyu Ye; Wenlong Shen; Minglei Shi; Yan Zhang; Cunshuan Xu; Zhihu Zhao
Journal:  PeerJ       Date:  2018-06-18       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.